Long noncoding RNA lncARSR confers resistance to Adriamycin and promotes osteosarcoma progression

One of the significant challenges for chemotherapy is the appearance of resistance to compounds. Although several signaling pathways have been implicated in the development of Adriamycin (ADM) resistance, mechanisms involved in ADM-resistant osteosarcoma progression remain unknown. The present study...

Descripción completa

Detalles Bibliográficos
Autores principales: Shen, Peng, Cheng, Yanfeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7220921/
https://www.ncbi.nlm.nih.gov/pubmed/32404870
http://dx.doi.org/10.1038/s41419-020-2573-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7220921/
https://www.ncbi.nlm.nih.gov/pubmed/32404870
http://dx.doi.org/10.1038/s41419-020-2573-2

Ejemplares similares